Cargando…
Facilitating oral COVID-19 therapy utilization through a pharmacy consult service
BACKGROUND: Two oral therapies, nirmatrelvir/ritonavir (Paxlovid) and molnupiravir (Lagevrio), are now available for the treatment of coronavirus disease 2019 (COVID-19). Treatment guidelines recommend using these agents for nonhospitalized adults with mild to moderate COVID-19 who are at high risk...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10116126/ https://www.ncbi.nlm.nih.gov/pubmed/37084811 http://dx.doi.org/10.1016/j.japh.2023.04.010 |